Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI Investigators. Nadarajah R, et al. Among authors: huber k. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):8-15. doi: 10.1093/ehjqcco/qcac067. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 36259751
Leisure Physical Activity, Sedentary Behavior, and Cardiovascular Health 2-7 Years after Pregnancy in the nuMoM2b HHS Cohort.
Gibbs BB, Modlin S, Merz NB, Haas DM, Khan SS, Lane A, McNeil RB, Varagic J, Huber K, Vasquez-Huot L, Catov JM; National Heart, Lung, and Blood Institute nuMoM2b Heart Health Study Network. Gibbs BB, et al. Among authors: huber k. Med Sci Sports Exerc. 2025 Feb 3. doi: 10.1249/MSS.0000000000003660. Online ahead of print. Med Sci Sports Exerc. 2025. PMID: 39898583
Characterizing High-Risk Enrollment Criteria and Impact on Clinical Outcomes in a Large Randomized Clinical Trial: Insights From the TWILIGHT Trial.
Steg PG, Nicolas J, Baber U, Sartori S, Zhang Z, Feng Y, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Marx SO, Kornowski R, Kunadian V, Vogel B, Oliva A, Mehta SR, Moliterno D, Sardella G, Krucoff M, Shlofmitz RA, Sharma S, Pocock S, Mehran R. Steg PG, et al. Among authors: huber k. Am Heart J. 2025 Jan 29:S0002-8703(25)00016-X. doi: 10.1016/j.ahj.2025.01.016. Online ahead of print. Am Heart J. 2025. PMID: 39889917
CDK4 inactivation inhibits apoptosis via mitochondria-ER contact remodeling in triple-negative breast cancer.
Ziegler DV, Parashar K, Leal-Esteban L, López-Alcalá J, Castro W, Zanou N, Martinez-Carreres L, Huber K, Berney XP, Malagón MM, Roger C, Berger MA, Gouriou Y, Paone G, Gallart-Ayala H, Sflomos G, Ronchi C, Ivanisevic J, Brisken C, Rieusset J, Irving M, Fajas L. Ziegler DV, et al. Among authors: huber k. Nat Commun. 2025 Jan 9;16(1):541. doi: 10.1038/s41467-024-55605-z. Nat Commun. 2025. PMID: 39788939 Free PMC article.
Phenomics-Based Discovery of Novel Orthosteric Choline Kinase Inhibitors.
Bauer LG, Ward JA, Díaz-Sáez L, Sundström Y, Tolvanen T, Alarcón Barrera JC, Kostidis S, Rogers CM, Panagakou I, Singh U, Rothweiler EM, Gonzalez Orta A, Kaniskan HÜ, Hu J, Jin J, Sievers S, Waldmann H, Giera M, Sundström M, Berg L, Huber KVM. Bauer LG, et al. Among authors: huber kvm. Angew Chem Int Ed Engl. 2024 Dec 30:e202420149. doi: 10.1002/anie.202420149. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39740997
Persistent Short Sleep Duration From Pregnancy to 2 to 7 Years After Delivery and Metabolic Health.
Kim M, Wiener LE, Gilbert J, McNeil RB, Reid KJ, Grobman WA, Facco F, Haas DM, Silver RM, Greenland P, Yee LM, Zee PC; Eunice Kennedy Shriver National Institute of Child Health and Human Development NuMoM2b and National Heart, Lung, and Blood Institute NuMoM2b Heart Health Study Network. Kim M, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2452204. doi: 10.1001/jamanetworkopen.2024.52204. JAMA Netw Open. 2024. PMID: 39724370 Free PMC article.
Management of dyslipidaemia in patients with comorbidities - facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver.
Frühwald L, Fasching P, Dobrev D, Kaski JC, Borghi C, Wassmann S, Huber K, Semb AG, Agewall S, Drexel H. Frühwald L, et al. Among authors: huber k. Eur Heart J Cardiovasc Pharmacother. 2024 Dec 24:pvae095. doi: 10.1093/ehjcvp/pvae095. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39719399
2,103 results